GoHealth Inc. (GOCO)
NASDAQ (CM) NASDAQ (CM) Primary 
XSTU 
GoHealth, Inc. (GOCO) Q3 2025 Earnings Call Transcript
GoHealth, Inc. ( GOCO ) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST Company Participants John Shave - Vice President of Investor Relations Vijay Kotte - CEO & Director Conference Call Participants Robert McGuire - Granite Research, LLC Patrick McCann - NOBLE Capital Markets, Inc., Research Division Benjamin Hendrix - RBC Capital Markets, Research Division James Sidoti - Sidoti & Company, LLC David Storms - Stonegate Capital Partners, Inc., Research Division Presentation Operator Good day, and welcome to the GoHealth Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
GoHealth (GOCO) Reports Q3 Loss, Lags Revenue Estimates
GoHealth (GOCO) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $2.06. This compares to a loss of $3.73 per share a year ago.
GoHealth, Inc. (GOCO) Q2 2025 Earnings Call Transcript
GoHealth, Inc. (NASDAQ:GOCO ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants John E. Shave - Vice President of Investor Relations Vijay Kumar Kotte - CEO & Director Conference Call Participants David Joseph Storms - Stonegate Capital Partners, Inc., Research Division Ilya Zubkov - Freedom Broker, Research Division James Philip Sidoti - Sidoti & Company, LLC Patrick Joseph McCann - NOBLE Capital Markets, Inc., Research Division Robert Miles McGuire - Granite Research, LLC Operator Good day, and welcome to the GoHealth Second Quarter 2025 Earnings Conference Call.
GoHealth (GOCO) Reports Q2 Loss, Lags Revenue Estimates
GoHealth (GOCO) came out with a quarterly loss of $1.23 per share versus the Zacks Consensus Estimate of a loss of $2.6. This compares to a loss of $0.75 per share a year ago.
Regulatory Winds & Execution Catalyze GoHealth's Upside
We initiate on GoHealth with a Strong Buy rating based on our view that the market underestimates both regulatory tailwinds and the execution-driven inflection in revenue and profitability. Our $20/share PT is based on a 0.23x forward P/S multiple applied to our FY26E revenue estimate and implies 246% upside from current levels. We model FY25E revenue of $890mn (+11.4% y/y) and FY26E revenue of $960mn (+7.9% y/y), both significantly ahead of consensus.
GoHealth, Inc. (GOCO) Q1 2025 Earnings Call Transcript
GoHealth, Inc. (NASDAQ:GOCO ) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ET Company Participants John Shave - Vice President of Investor Relation Vijay Kotte - Chief Executive Officer Brendan Shanahan - Chief Financial Officer Conference Call Participants Rob McGuire - Granite Research Pat McCann - Noble Capital Markets James Sidoti - Sidoti & Company Dave Storms - Stonegate Capital Partners Operator Good morning, and welcome to GoHealth's First Quarter 2025 Earnings Conference Call. My name is Tanya, and I will be your operator for today's call.
GoHealth (GOCO) Reports Q1 Loss, Lags Revenue Estimates
GoHealth (GOCO) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.89 per share a year ago.
Down -24.97% in 4 Weeks, Here's Why GoHealth (GOCO) Looks Ripe for a Turnaround
GoHealth (GOCO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
GoHealth, Inc. (GOCO) Q4 2024 Earnings Call Transcript
GoHealth, Inc. (NASDAQ:GOCO ) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants John Shave - Vice President, Investor Relation Vijay Kotte - Chief Executive Officer Brendan Shanahan - Chief Financial Officer Conference Call Participants Ben Hendrix - RBC Capital Markets Pat McCann - Noble Capital Markets Robert McGuire - Granite Research Jim Sidoti - Sidoti & Company Dave Storms - Stonegate Inc. Operator Good morning, and welcome to the GoHealth Fourth Quarter and Full Year 2024 Earnings Conference Call. My name is Olivia, and I will be your operator for today's call.
GoHealth (GOCO) Surpasses Q4 Earnings and Revenue Estimates
GoHealth (GOCO) came out with quarterly earnings of $2.41 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $0.60 per share a year ago.
GoHealth: Smart Moves Are Paying Off
GoHealth Inc has put together a string of several quarters with positive operating cash flow on a trailing-twelve month basis, showing clear signs of stabilizing. During the third quarter of 2024, they acquired the agency e-TeleQuote on highly favorable terms, expanding their business with little immediate downside risk. Subsequent to the close of the third quarter, GoHealth also refinanced its debt on improved terms, and the interest savings should be meaningful to income and cash flow.
GoHealth, Inc. (GOCO) Q3 2024 Earnings Call Transcript
GoHealth, Inc. (NASDAQ:GOCO ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants John Shave - Vice President, Investor Relation Vijay Kotte - Chief Executive Officer Brendan Shanahan - Chief Financial Officer Conference Call Participants Patrick McCann - Noble Capital Markets Ben Hendrix - RBC Capital Markets Robert McGuire - Granite Research James Sidoti - Sidoti Operator Good morning and welcome to GoHealth's Third Quarter 2024 Earnings Conference Call. My name is Hope, and I will be your operator for today's call.
